The landscape has shifted in the past year
If you were diagnosed a few years ago, your care plan probably followed a familiar pattern: metformin, lifestyle advice, and a finger-prick test every now and then. That picture has changed considerably. In 2026, NHS England announced plans to offer a weekly injectable GLP-1 treatment to over a million people as part of heart and stroke risk reduction, and real-time glucose monitoring is moving beyond the specialist diabetes clinic.
None of this happened by accident. It came out of research, and much of that research is running through UK-based trials today. The FreeDM2 trial, led by researchers at the University of Nottingham and Imperial College London, made headlines earlier this year when it showed that real-time continuous glucose monitoring significantly improved blood sugar control in adults with type 2 diabetes who use basal insulin. The results, published in a leading medical journal and presented at the Diabetes UK Professional Conference in Liverpool, are now shaping how NHS teams think about technology.
For patients, the message is simple: participating in a diabetes management trial can give you access to approaches that most people will only see years from now.
The real pain points behind the research
Ask anyone managing type 2 diabetes what frustrates them most and you will hear a few recurring themes.
First is the uncertainty around food. Blood sugar responses vary from person to person, and generic dietary advice often falls flat. Second is medication fatigue, the sense of taking tablets or injections daily without really knowing whether they are the best option. Third is the emotional weight of the condition, which rarely gets discussed in a standard appointment. Diabetes distress is real, and research is only now catching up with how much it affects outcomes.
A fourth issue is access. Many people outside major cities feel cut off from the newest treatments, assuming trials only happen in London or Manchester. That assumption no longer holds. The Bradford and West Yorkshire Commercial Research Delivery Centre launched two new investigational trials in July 2026, evaluating a weekly injection designed to help with weight, blood sugar and overall health, recruiting people aged 18 and over living with obesity or overweight, with or without type 2 diabetes. Sites now span Birmingham, Blackpool, Bristol, Newcastle and beyond.
What is actually recruiting across the UK
The range of open studies is broader than most people expect. Industry-sponsored phase 2 trials, such as the Eli Lilly study of a new therapy in people already on stable doses of established injectables, are recruiting at multiple UK cities. University-led projects are running too. Ulster University is examining whether omega-3 supplements can slow the progression of type 2 diabetes, while researchers at the University of the West of England in Bristol are testing a four-week digital programme designed to reduce diabetes distress.
Each study answers a slightly different question, and that is worth reflecting on before you apply. A technology trial might compare continuous glucose monitoring against traditional finger-prick testing. A medication trial will investigate a new drug, usually against a placebo. A lifestyle programme trial, like the NHS soups and shakes initiative that showed around one in three participants achieved remission, focuses on behaviour and diet. Knowing which question interests you helps you choose the right fit.
The table below gives a snapshot of the main categories of diabetes management trials open to UK residents this year.
| Trial type | Example currently running | What it involves | Typical access | Benefits | Points to weigh up |
|---|
| Glucose monitoring | FreeDM2-style CGM studies | Wearing a small sensor that tracks glucose continuously | NHS-funded for eligible participants; sponsors cover trial costs | Real-time insights into food and sleep patterns | Requires wearing a device and sharing data with the research team |
| Weekly injection (GLP-1) | Bradford CRDC dose studies | Self-administered injection once a week | Costs covered by the study sponsor | Weight and blood sugar improvements in one treatment | Regular clinic visits and possible side effects |
| Remission programme | NHS soups and shakes rollout | Structured low-calorie meal replacement over several months | NHS programme for eligible patients | Realistic chance of remission, not just management | Demanding routine and ongoing support needed |
| Digital wellbeing | UWE Bristol emotional support study | Self-guided four-week online programme | Open to adults across the UK | Tackles diabetes distress alongside glucose control | Self-motivation is essential |
| Supplement study | Ulster University omega-3 trial | Daily supplement capsules with regular testing | Research clinic attendance in Coleraine | Could inform dietary guidance for prediabetes | Findings are exploratory, not guaranteed benefits |
How to find a trial near you
The process is more straightforward than many assume. Start with the NHS register, which lets you search for diabetes research studies by region and sign up to be contacted when something relevant opens. The ClinicalTrials.gov registry and the UK ISRCTN database list current studies with eligibility criteria and contact details, and Diabetes UK runs a dedicated trials page updated throughout the year.
A practical first step is to mention your interest at your next routine appointment. Your diabetes team can tell you whether you meet a study's inclusion criteria, and some trials specifically recruit through GP practices rather than hospitals. If you live in Yorkshire, the Bradford centre is an obvious starting point. If you are in Scotland or the South West, check with your local NHS research network, because many universities now run satellite sites to widen access.
Before you commit, read the participant information sheet carefully and ask three questions: how often must I attend, what happens to my glucose data, and will my usual medication change during the study. Every trial must have ethics approval and informed consent, and you can withdraw at any time without affecting your standard NHS care.
One more thing worth knowing: studies often reimburse reasonable travel costs and time. The exact arrangements vary, but the principle is that taking part in research should not leave you out of pocket.
The bigger picture
Trials are not just about testing new pills. The 2026 wave of UK research is asking harder questions about everyday life, about how monitoring feels, how digital tools support emotional health, and how ordinary people sustain remission over years. By joining a study, you contribute answers that will shape treatment decisions for the next generation of patients.
If you are living with type 2 diabetes, prediabetes or excess weight, this is a genuinely good moment to look at what is recruiting. Speak to your GP, browse the Diabetes UK trials page, and consider whether one of the open studies matches your situation. You might not only improve your own care, but help others avoid the guesswork you have had to live with.
研究の知恵